TickerFactsScreenerDevelopers

Altimmune, Inc. (ALT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$23.55M2011: -$11.73M2012: -$6.27M2013: -$10.84M2014: -$10.19M2015: -$3.40M2016: -$11.09M2017: -$52.05M2018: -$42.83M2019: -$21.46M2020: -$54.80M2021: -$96.91M2022: -$87.74M2023: -$95.93M2024: -$103.17M2025: -$94.49M-$94.49M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$94.49M+8.4%
2024-$103.17M-7.6%
2023-$95.93M-9.3%
2022-$87.74M+9.5%
2021-$96.91M-76.9%
2020-$54.80M-155.3%
2019-$21.46M+49.9%
2018-$42.83M+17.7%
2017-$52.05M-369.2%
2016-$11.09M-226.0%
2015-$3.40M+66.6%
2014-$10.19M+6.0%
2013-$10.84M-73.0%
2012-$6.27M+46.6%
2011-$11.73M+50.2%
2010-$23.55M—